Delpor is a clinical stage life sciences company that utilizes innovative drug delivery technologies to develop once yearly therapies for chronic diseases. The Company’s primary focus is in CNS conditions including Schizophrenia, Opioid Use Disorder, Spasticity, Parkinson’s, Alzheimer’s, and Multiple Sclerosis.